PhRMA Moves To Head Off Clinton Assault; Considers Incremental Rx Benefit
Executive Summary
The Pharmaceutical Research & Manufacturers of America is attempting to defuse some of the Clinton Administration's rhetoric on drug costs to the elderly ahead of the State of the Union address.
You may also be interested in...
Senate Medicare Rx Work Begins; Merck Joins In Frist Briefing
Merck is playing a key role in the preliminary Medicare legislative drafting effort in the Senate
Senate Medicare Rx Work Begins; Merck Joins In Frist Briefing
Merck is playing a key role in the preliminary Medicare legislative drafting effort in the Senate
J&J, Lilly & Merck Reassure Investors About Medicare Reform Process
The lessons from the health care reform debate in the mid-1990s will ensure a more "sensible" debate over health care in 2000, J&J CEO Ralph Larsen told analysts during a Jan. 25 conference call.